Overview

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy
Phase:
Phase 4
Details
Lead Sponsor:
Innovative Medical
Treatments:
Brimonidine Tartrate
Dorzolamide
Latanoprost